cetirizine has been researched along with Melanoma in 1 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
Excerpt | Relevance | Reference |
---|---|---|
"The clinical observation showed a potential additive effect of anti-PD-1 agents and cetirizine in patients with advanced melanoma." | 8.12 | Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization. ( Ascierto, PA; Borzillo, V; Budillon, A; Caracò, C; Cavalcanti, E; Cortellini, A; De Cristofaro, T; Fiore, F; Lastoria, S; Maiolino, P; Mallardo, D; Muto, P; Palla, M; Paone, M; Petrillo, A; Pignata, S; Scarpato, L; Simeone, E; Sparano, F; Vanella, V; Vitale, MG; Warren, S, 2022) |
"The clinical observation showed a potential additive effect of anti-PD-1 agents and cetirizine in patients with advanced melanoma." | 4.12 | Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization. ( Ascierto, PA; Borzillo, V; Budillon, A; Caracò, C; Cavalcanti, E; Cortellini, A; De Cristofaro, T; Fiore, F; Lastoria, S; Maiolino, P; Mallardo, D; Muto, P; Palla, M; Paone, M; Petrillo, A; Pignata, S; Scarpato, L; Simeone, E; Sparano, F; Vanella, V; Vitale, MG; Warren, S, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Mallardo, D | 1 |
Simeone, E | 1 |
Vanella, V | 1 |
Vitale, MG | 1 |
Palla, M | 1 |
Scarpato, L | 1 |
Paone, M | 1 |
De Cristofaro, T | 1 |
Borzillo, V | 1 |
Cortellini, A | 1 |
Sparano, F | 1 |
Pignata, S | 1 |
Fiore, F | 1 |
Caracò, C | 1 |
Maiolino, P | 1 |
Petrillo, A | 1 |
Cavalcanti, E | 1 |
Lastoria, S | 1 |
Muto, P | 1 |
Budillon, A | 1 |
Warren, S | 1 |
Ascierto, PA | 1 |
1 other study available for cetirizine and Melanoma
Article | Year |
---|---|
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization.
Topics: Cetirizine; Humans; Interferon-gamma; Macrophages; Melanoma; Programmed Cell Death 1 Receptor; Retro | 2022 |